ProAssurance Co. (NYSE:PRA – Get Free Report) was the target of a significant decline in short interest in November. As of November 30th, there was short interest totalling 571,000 shares, a decline of 16.1% from the November 15th total of 680,600 shares. Based on an average daily volume of 265,900 shares, the short-interest ratio is currently 2.1 days. Approximately 1.1% of the shares of the stock are sold short.
Analysts Set New Price Targets
PRA has been the subject of several recent analyst reports. Truist Financial upped their price objective on ProAssurance from $14.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, November 12th. Piper Sandler cut shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 target price for the company. in a report on Monday, November 11th. Finally, StockNews.com raised shares of ProAssurance from a “hold” rating to a “buy” rating in a report on Tuesday, December 10th.
View Our Latest Research Report on ProAssurance
Institutional Inflows and Outflows
ProAssurance Trading Down 0.5 %
Shares of PRA stock opened at $16.65 on Friday. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $851.75 million, a P/E ratio of 20.06 and a beta of 0.28. ProAssurance has a twelve month low of $10.76 and a twelve month high of $17.79. The stock’s fifty day simple moving average is $15.99 and its 200 day simple moving average is $14.01.
About ProAssurance
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Recommended Stories
- Five stocks we like better than ProAssurance
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Differences Between Momentum Investing and Long Term Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Most Volatile Stocks, What Investors Need to Know
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.